![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, March 06, 2018 3:33:37 PM
With regards to manufacturing, I have shown how others do it now. Only advantage we will have is we cut out having to outsource manufacturing. But others are manufacturing themselves, utilizing technologies from others.
Manufacturing for Pluristem will remain useless, until they get a product to market. Well not entirely, as they don't have a significant manufacturing cost for their own trials. ARS really is their only near to mid term hope. Without something from ARS, they will need significantly more funds. $50 million according to Edison report, by 2020.
If you want to respond, try to counter THIS argument about THIS post, and not come up with something totally different, as you have a tendency to do.
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM